Drug Stidy Myonal

Name of Drug Classifica tion of Drug Mechanism of Action Indication Contraindications Side Effects Nursing Responsibilities Generi c Name: Eperis one HCl Brand Name: Myonal Pharmacolo gic: Muscle relaxant Eperisone HCl suppresses the activity of afferent nerve fibers (Ia fibers) from human muscle spindles Therapeuti c Effects: Relaxes muscle. Muscle relaxant. Improvement of myotonic symptoms eg, in cervical syndrome, periarthritis of the shoulder, lumbago, etc. Spastic paralysis caused by the following diseases: Cerebrovascular disorders, spastic spinal paralysis, cervical spondylosis, sequela of trauma (spinal and head injury), spinal vascular disorders and other encephalomyelopathies . History of hypersensiti vity to eperisone HCl and to any of the ingredients of Myonal. Shock and Anaphylactoid Reactions: Since shock and anaphylactoid reactions may occur, patients should be carefully observed. In the event of symptoms eg, redness, itching, urticaria, edema of the face or other parts and dyspnea Weakness, light- headedness, sleepiness or other symptoms may occur. In the event of such symptoms, the dosage should be reduced or treatment discontinued . Patients should be cautioned against engaging in potentially

Upload
rez-gioz-pizarro-apego
Category

Documents
view
16
download
2

Embed Size (px):

description

drug study

Transcript of Drug Stidy Myonal

Name of Drug

Classification of Drug

Mechanism of Action

Indication Contraindications Side Effects Nursing Responsibilities

Generic Name:Eperisone HClBrand Name:Myonal

Pharmacologic:Muscle relaxant

Eperisone HCl suppresses the activity of afferent nerve fibers (Ia fibers) from human muscle spindlesTherapeutic Effects:Relaxes muscle.

Muscle relaxant. Improvement of myotonic symptoms eg, in cervical syndrome, periarthritis of the shoulder, lumbago, etc.Spastic paralysis caused by the following diseases: Cerebrovascular disorders, spastic spinal paralysis, cervical spondylosis, sequela of trauma (spinal and head injury), spinal vascular disorders and other encephalomyelopathies.

History of hypersensitivity to eperisone HCl and to any of the ingredients of Myonal.

Shock and Anaphylactoid Reactions: Since shock and anaphylactoid reactions may occur, patients should be carefully observed. In the event of symptoms eg, redness, itching, urticaria, edema of the face or other parts and dyspnea

Weakness, light-headedness, sleepiness or other symptoms may occur. In the event of such symptoms, the dosage should be reduced or treatment discontinued.

Patients should be cautioned against engaging in potentially hazardous activities requiring alertness, such as operating machinery or driving a car